Evidence map›Paper›PMID 33542070›Full record

ArticleTobacco control2022

Early adoption of heated tobacco products resembles that of e-cigarettes.

Shu-Hong Zhu, Julian Ong, Shiushing Wong, Adam Cole, Yue-Lin Zhuang, Yuyan Shi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tobacco control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Heated tobacco product (IQOS) induced pulmonary infiltrates.Respiratory medicine case reports · 2024
    Article
  5. Article
  6. Cue Reactivity Effects of Heated Tobacco Product Use in Current, Former, and Never Smokers in the United States.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shu-Hong ZhuHerbert Wertheim School of Public Healh, University of California San Diego, La Jolla, California, USA szhu@ucsd.edu.ORCID 0000-0002-4149-3441
Julian OngMoores Cancer Center, University of California San Diego, La Jolla, California, USA.
Shiushing WongMoores Cancer Center, University of California San Diego, La Jolla, California, USA.
Adam ColeFaculty of Health Science, University of Ontario Institute of Technology Faculty of Health Sciences, Oshawa, Ontario, Canada.
Yue-Lin ZhuangMoores Cancer Center, University of California San Diego, La Jolla, California, USA.
Yuyan ShiFamily Medicine and Public Health, University of California San Diego School of Medicine, La Jolla, California, USA.ORCID 0000-0001-9293-0659

Funding

Neighborhood Physical, Economic, and Socioeconomic Environment In Relation to Marijuana Use and DisorderR01DA042290 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHI, YUYAN · 2017 to 2020
$2.6M
NIDA NIH HHS R01 DA042290
6 · The paper itself

Abstract

backgroundHeated tobacco products (HTP) generate nicotine-containing aerosol by heating tobacco rather than burning it. The US Food and Drug Administration (FDA) has recently authorised the sale of one HTP brand, iQOS, in the USA. This study examined the awareness, use and risk perceptions of HTP in the USA following FDA authorisation.

methodsA national probability sample of 20 449 US adults completed an online survey between November 2019 and February 2020. In addition to assessing awareness and use of HTP, two ratios were calculated: the ratio of those who experimented with HTP given that they had heard about it (E/H) and the ratio of those who currently used HTP given experimentation (C/E). These ratios for HTP were compared against those for e-cigarettes from a similar national survey in 2012.

resultsOverall, 8.1% of respondents had heard of HTP. Only 0.55% had tried and 0.10% were current users. The rate of experimentation among those who heard about HTP and the rate of current use among experimenters were, however, similar to those for e-cigarettes in 2012: E/H and C/E for HTP were 6.8% and 18.2%, respectively; and 10.7% and 17.8%, respectively for e-cigarettes. The majority of respondents considered HTP either less harmful than (11.6%), or equally harmful as e-cigarettes (42.7%).

conclusionsOnly a small fraction of US population in 2020 have tried any HTP. However, the similarity in early adoption rates following awareness, suggests that future adoption for HTP may be similar to that for e-cigarettes, if HTP are marketed more aggressively.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsAdultHumansNicotineTobacco UseNicotinenon-cigarette tobacco productspublic opinionpublic policy

Identifiers

PMID33542070
PMCPMC8333247

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.